Site Map Site Map of http://www.researchandmarkets.com - Site Map - Pharmaceuticals and Healthcare    - Pharmaceuticals 1 (Latest Titles)    Pharmaceuticals 2    Pharmaceuticals 3    Pharmaceuticals 4    Pharmaceuticals 5       - Oncology  << You are in This Category     - Lung Cancer     - Breast Cancer     - Prostate Cancer     - Leukemia     - Lymphoma     - Ovarian Cancer     - Colon Cancer     - Cervical Cancer     - Brain Cancer     - Bladder Cancer #  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z   A An Evaluation of Products and Technologies for Molecular Diagnostics w... static version printer friendly Analytical Tool - Angiogenesis in Oncology static version printer friendly pdf version Analytical Tool - Apoptosis in Oncology static version printer friendly pdf version Analytical Tool - Breast Cancer R&D: A Comprehensive Guide 2005 static version printer friendly Analytical Tool - Cancer Therapeutic Antibodies static version printer friendly pdf version Analytical Tool - Cancer Vaccines static version printer friendly pdf version Analytical Tool - Colorectal Cancer static version printer friendly pdf version Analytical Tool - Hematological Cancers static version printer friendly pdf version Analytical Tool - Melanoma static version printer friendly pdf version Analytical Tool - Protein Kinase Inhibitors in Oncology 2009 static version printer friendly pdf version Angiogenesis in Oncology: Drug Pipeline Update 2009 static version printer friendly pdf version Angiogenesis Inhibitors 2001 - State-of-the-Science and Strategic Oppo... static version printer friendly Antibodies in Oncology: Drug Pipeline Update 2009 static version printer friendly pdf version Antibody drug conjugates for cancer treatment: Clinical Trial Pipeline... static version printer friendly pdf version Antibody Drug Target Atlas in Oncology static version printer friendly pdf version Anticancer Therapeutics static version printer friendly pdf version Antihormonal Therapy Cancer Brands - Careful Lifecycle Management Need... static version printer friendly pdf version Antisense cancer therapies static version printer friendly pdf version Antitumor Biologics - Strategies for Success in an Expanding Market static version printer friendly pdf version Apoptosis in Oncology: Drug Pipeline Update 2008 static version printer friendly pdf version Apoptosis in Oncology: Drug Pipeline Update 2009 static version printer friendly pdf version Apoptosis: Promise Or Deception? static version printer friendly Approval Outlook for Avastin® as a Breast Cancer Treatment: A Survey o... static version printer friendly pdf version Aurora Kinase inhibitors - The dawn of a new approach to cancer static version printer friendly ^ Top B Benign Prostatic Hyperplasia: Expanding the drug treated population static version printer friendly pdf version Biomarker Technology Platforms for Cancer Diagnoses and Therapies static version printer friendly pdf version Biomedical Applications of Nanotechnology static version printer friendly pdf version Bisphosphonates and Other Bone-Targeting Compounds in the Treatment of... static version printer friendly pdf version Bisphosphonates Update - The Treatment and Prevention of Bone Metastas... static version printer friendly Bladder Cancer - High Recurrence Rates, Targeted Therapy to Stem the F... static version printer friendly Blood Cancer Drug Discoveries: What the future holds static version printer friendly pdf version Board Review in Medical Oncology static version printer friendly pdf version Board Reviews in Hematology and Medical Oncology static version printer friendly pdf version Breast Cancer - Changing Treatment Paradigms For Local And Locally Adv... static version printer friendly Breast Disease Diagnosis and Therapy Markets: Europe and Asia-Pacific static version printer friendly pdf version Brief Report: CD40 and CD40L (CD154) Agonists and Antagonists static version printer friendly pdf version Brief Report: Death Receptors TRAIL-R1/2 static version printer friendly pdf version Building Better Cancer Vaccines: The Progress and Promise of R&D static version printer friendly pdf version Building on Early Successes of Immunomodulators in the Fight Against C... static version printer friendly pdf version ^ Top C Can Denosumab Achieve Superiority For The Prevention Of SREs In Cancer... static version printer friendly pdf version Cancer - Gastrointestinal (Stomach) Cancer static version printer friendly pdf version Cancer Biology & Therapy Journal static version printer friendly pdf version Cancer Biomarkers: New Tools for Transforming Cancer Management static version printer friendly pdf version Cancer Bundle static version printer friendly pdf version Cancer Cell Therapy Markets static version printer friendly pdf version Cancer Chemotherapy: Basic Science to the Clinic static version printer friendly pdf version Cancer Diagnostic Technologies: Assessment of Current and Emerging Tec... static version printer friendly pdf version Cancer Diagnostic Testing Instrumentation: Operating Characteristics, ... static version printer friendly pdf version Cancer Diagnostic Testing World Markets static version printer friendly Cancer Diagnostics Market: New Product Development Opportunities, Mark... static version printer friendly pdf version Cancer Diagnostics with DNA Microarrays static version printer friendly pdf version Cancer Diagnostics: Early Detection of Breast, Prostate and Colorectal... static version printer friendly Cancer Drug Delivery: Managing Cancer Patients Beyond Oral Formulation... static version printer friendly Cancer Drug Discoveries: What the Future Holds static version printer friendly Cancer Drug Discoveries: What the Future Holds: Colorectal Cancer Chap... static version printer friendly pdf version Cancer Drug Discoveries: What the Future Holds: Renal Cancer Chapter static version printer friendly pdf version Cancer Drug Resistance static version printer friendly pdf version Cancer genomics: The impact of genomic advances in oncology static version printer friendly pdf version Cancer Head and Neck Cancer  static version printer friendly pdf version Cancer Imaging static version printer friendly pdf version Cancer in Children and Young People static version printer friendly pdf version Cancer Kidney Cancer  static version printer friendly pdf version Cancer Liver Cancer  static version printer friendly pdf version Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market static version printer friendly pdf version Cancer Melanoma or Skin Cancer  static version printer friendly pdf version Cancer Multiple Myeloma  static version printer friendly pdf version Cancer Pancreatic Cancer  static version printer friendly pdf version Cancer Personalized Medicine 2008 static version printer friendly pdf version Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market Opportu... static version printer friendly pdf version Cancer Therapeutics - Market Insight and R&D Pipeline Analysis static version printer friendly pdf version Cancer Therapeutics 2006: Market Dynamics and R&D Trends static version printer friendly Cancer Therapeutics Markets static version printer friendly pdf version Cancer Therapies - Global Market Opportunities static version printer friendly pdf version Cancer Therapies - Global Strategic Business Report static version printer friendly pdf version Cancer Therapies - Is the United States Always the Most Expensive Mark... static version printer friendly pdf version Cancer Therapies Face Increasing Reimbursement Pressures in Europe and... static version printer friendly pdf version Cancer Vaccine Development and Projected Market Size static version printer friendly pdf version Cancer Vaccine Developments to 2013 static version printer friendly pdf version Cancer Vaccines and Tumor Immunity static version printer friendly pdf version Cancer Vaccines Fantasy or Future? static version printer friendly Cancer Vaccines Market, 2006-2010 static version printer friendly pdf version Cancer Vaccines: A Class Poised For Expansion? static version printer friendly Cancer Vaccines: Drug Pipeline Update 2009 static version printer friendly pdf version Cancer Vaccines: Measuring Market Potential static version printer friendly Cancer: From Mechanisms to Therapeutic Approaches static version printer friendly pdf version Cell Junctions: Adhesion, Development, and Disease static version printer friendly pdf version Cervical Cancer: Is Society Ready For a Preventative Answer? static version printer friendly Challenges and Opportunities in Developing Chemopreventive Agents static version printer friendly pdf version Challenges in Oncology Clinical Trial Design static version printer friendly pdf version Changes in U.S. Oncology Drug Reimbursement: Medicare Sets the Pace static version printer friendly pdf version Chemoprevention of Cancer and DNA Damage by Dietary Factors static version printer friendly pdf version Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer... static version printer friendly China Anti-Cancer Drug Market Report 2008 static version printer friendly pdf version Chinese Journal of Cancer static version printer friendly pdf version Chinese Markets for Anti-Tumor Drugs  static version printer friendly pdf version Chinese Markets for Cancer Treatment Drugs static version printer friendly Classes of Drugs Used to Treat Breast Cancer static version printer friendly Colony Stimulating Factors State-of-the-Science and Strategic Opportun... static version printer friendly Colorectal Cancer Drug Pipeline Update 2009 static version printer friendly pdf version Commercial Insight Top 20 Cancer Therapeutics static version printer friendly pdf version Commercial Insight: Antihormonal Cancer Therapies static version printer friendly pdf version Commercial Insight: Cytotoxic Therapy Cancer Brands - Looming Patent E... static version printer friendly pdf version Commercial Insight: Targeted Therapy Cancer Brands - High Growth Marke... static version printer friendly pdf version Commercial Insight: Top 20 Cancer Therapy Brands - Sales of targeted t... static version printer friendly pdf version Companion Diagnostics in Personalized Medicine and Cancer Therapy static version printer friendly pdf version Companion Diagnostics: Enabling Personalized Medicines in Cancer static version printer friendly pdf version Competitive Insights to Anti-Angiogenic Drug R&D in Oncology static version printer friendly pdf version Competitive Outlook on Antiangiogenesis and Vascular Targeting in Onco... static version printer friendly pdf version Competitive Outlook on Non-Antibody Based Cancer Vaccines static version printer friendly pdf version Competitor Analysis VEGF and VEGF-R Agonists and Antagonists static version printer friendly pdf version Competitor Analysis: CD3 Antagonists static version printer friendly pdf version Competitor Analysis: CHK and KSP/Eg5 Inhibitors static version printer friendly pdf version Competitor Analysis: G-CSF & GM-CSF static version printer friendly pdf version Competitor Analysis: Hypoxia-Inducible Factor (HIF) static version printer friendly pdf version Competitor Analysis: PARP Inhibitors static version printer friendly pdf version Competitor Analysis: PDGF-R Agonists and Antagonists static version printer friendly pdf version Competitor Analysis: PI3K-Akt-mTOR Pathway Inhibitors static version printer friendly pdf version Competitor Analysis: Plk-1 Inhibitors static version printer friendly pdf version Competitor Analysis: Raf Inhibitors static version printer friendly pdf version Complete Target Atlas in Oncology Drug Development: From Tumor to Targ... static version printer friendly pdf version CRC Drug Pipeline Update 2005 static version printer friendly Current and Emerging Cancer Diagnostic Tests: Emerging Assays and Comp... static version printer friendly pdf version Current and Future Therapies for Colorectal Cancer - A Therapeutic & C... static version printer friendly Currently Druggable in Colorectal Cancer: A Drug Target Competitive An... static version printer friendly pdf version Currently Druggable in Melanoma: A Drug Target Competitive Analysis static version printer friendly pdf version Cytogen Corporation - SWOT Analysis static version printer friendly pdf version Cytogen Corporation - SWOT Framework Analysis static version printer friendly pdf version Cytotoxics for Lung Cancer Therapy static version printer friendly ^ Top D Developments in Oncolytic Viruses - An Emerging Approach to Cancer The... static version printer friendly Disease and Therapy Review: Melanoma static version printer friendly pdf version Drug Delivery in Cancer - Technologies, Markets and Companies static version printer friendly pdf version Drug Delivery Systems in Cancer Therapeutics static version printer friendly pdf version Drug Delivery Technology - Revolutionizing Cancer Therapies static version printer friendly pdf version Drugs of Tommorow 2002: Breast Cancer static version printer friendly Drugs of Tomorrow 2000: Lung Cancer - New Partners For Old Regimens static version printer friendly Drugs of Tomorrow 2000: Prostate Cancer - Hormonals and Beyond static version printer friendly Drugs of Tomorrow 2001: Cancer Overview static version printer friendly Drugs of Tomorrow 2001: Lung Cancer static version printer friendly Drugs of Tomorrow 2002: Colorectal Cancer static version printer friendly Drugs of Tomorrow: Cancer Overview static version printer friendly Drugs of Tomorrow: Cancer Overview - The synergistic advance: innovati... static version printer friendly Drugs Used in Bladder Cancer Therapy static version printer friendly ^ Top E Educational Review Manual in Medical Oncology static version printer friendly pdf version Elan Corporation - SWOT Framework Analysis static version printer friendly pdf version Emerging Opportunities in Cancer Nanomedicine static version printer friendly pdf version Emerging Technologies: Stem Cells, Genes and Monoclonal Antibodies static version printer friendly Enabling Oncology Diagnostics: Predictive Biomarkers Based on Genes, P... static version printer friendly pdf version Erythropoietin (EPO) Stimulating Agents: Impact of Proposed CMS Guidel... static version printer friendly pdf version Erythropoietin (EPO) Stimulating Agents: Trends in use in Oncology - A... static version printer friendly pdf version European Bladder Cancer Therapeutics Markets static version printer friendly pdf version European Cancer IVD Market static version printer friendly pdf version European Head and Neck Cancer Therapeutics Markets static version printer friendly pdf version European Support Cancer Therapy static version printer friendly pdf version European Womens Cancer Pharmaceuticals Markets static version printer friendly pdf version Eyelid Tumors, 2nd Edition static version printer friendly pdf version ^ Top F Forecast Insight: Top 20 Cancer Therapy Brands  static version printer friendly pdf version Future Oncology static version printer friendly ^ Top G Gastric Cancer - Targeted Therapies Compete for First-to-Market Status... static version printer friendly pdf version Gastric Cancer - Targeted Therapies Home In On a Neglected Tumor Type static version printer friendly pdf version Gastric Cancer: Looking to the East for Inspiration? static version printer friendly Gastrointestinal (Stomach) Cancer Drug Pipeline Report static version printer friendly pdf version Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report static version printer friendly pdf version Generic Cancer Market - New Legislation and a Wave of Patent Expiries ... static version printer friendly Global Cancer Focus Company Directory static version printer friendly pdf version Global Cancer Treatment Forecast to 2012 static version printer friendly pdf version Global Neurosurgical Product Markets static version printer friendly pdf version Global Pipeline Review & Analysis of Hematological Malignancies static version printer friendly pdf version Global Stem Cell and Advanced Technologies Market static version printer friendly pdf version ^ Top H Head and Neck Cancer - Innovations to Change the Face of Treatment static version printer friendly Head and Neck Cancer Drug Pipeline Report static version printer friendly pdf version Head and Neck Cancer Therapy Area Pipeline Report static version printer friendly pdf version Helical/Arc-Based Radiation Oncology Equipment Assessment static version printer friendly pdf version Hematological Cancers - A Therapeutic & Competitive Insight static version printer friendly pdf version Hematological Cancers Drug Pipeline Update 2009 static version printer friendly pdf version ^ Top I Immunotherapy in Oncology: Drug Pipeline Update 2009 static version printer friendly pdf version Immunotherapy in Oncology: Gaining Momentum static version printer friendly pdf version Industry Analysis - How Companies Can Maintain the Market Success of C... static version printer friendly pdf version Infections Causing Human Cancer static version printer friendly pdf version Innovations in Cancer: Novel Therapeutics, New Diagnostics and Future ... static version printer friendly pdf version Innovative Agents in Lung and Colorectal Cancer - Another Step Nearer ... static version printer friendly pdf version Innovative and Targeted Cancer Therapies: Key Technologies, New Applic... static version printer friendly pdf version Issues; Trends and Prevalence in the European Cancer Therapy Market- N... static version printer friendly pdf version ^ Top J Japanese Cancer Market: Who Will Emerge Ahead? static version printer friendly pdf version ^ Top K Key Trends in European Patient Monitoring Systems Market static version printer friendly pdf version Key Trends in the Political and Reimbursement Environment for Cancer D... static version printer friendly pdf version Kidney Cancer Drug Pipeline Report static version printer friendly pdf version Kidney Cancer Therapy Area Pipeline Report static version printer friendly pdf version ^ Top L Large Pharma: 2004 A Year Of Progress static version printer friendly Latin American Oncology Therapeutics Markets static version printer friendly pdf version Launching Next Generation Oncology Products: Evolving Strategies in a ... static version printer friendly pdf version Leading Cancer Diagnostics Market Players: Strategic Assessments of Ma... static version printer friendly pdf version Liver Cancer Drug Pipeline Report static version printer friendly pdf version Liver Cancer Drug Pipeline Update 2009 static version printer friendly pdf version Liver Cancer Therapy Area Pipeline Report static version printer friendly pdf version Looking at the Cancer Therapy Market static version printer friendly pdf version Lymphoma Therapy Area Pipeline Report static version printer friendly pdf version ^ Top M Market Leaders in Oncology 2004 - Roche and Genentech Continue to Blaz... static version printer friendly pdf version Market Potential of ACAPODENE® FOR ADT-Associated Osteoporosis: A Pane... static version printer friendly pdf version MarketWatch: Cancer static version printer friendly Melanoma Drug Pipeline Update 2009 static version printer friendly pdf version Melanoma or Skin Cancer Drug Pipeline Report static version printer friendly pdf version Melanoma or Skin Cancer Therapy Area Pipeline Report static version printer friendly pdf version MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2... static version printer friendly pdf version MicroRNA Profiling in Cancer: A Bioinformatics Perspective static version printer friendly pdf version Molecular Cancer Therapeutics: Strategies for Drug Discovery and Devel... static version printer friendly Molecular-Targeted Pharmacotherapy in Myeloma: Clinical and Strategic ... static version printer friendly Multiple Myeloma Drug Pipeline Report static version printer friendly pdf version Multiple Myeloma Therapy Area Pipeline Report static version printer friendly pdf version ^ Top N New Approaches to the Treatment of Non-Hodgkin's Lymphoma static version printer friendly pdf version New Concepts in Cancer Therapeutics static version printer friendly Niche Cancers 2001: Acute Myeloid Leukemia static version printer friendly Niche Cancers 2001: Endometrial Carcinoma static version printer friendly Niche Cancers 2001: Gastric Cancer static version printer friendly Niche Cancers 2001: Glioblastoma static version printer friendly pdf version Niche Cancers 2001: Head and Neck Cancer static version printer friendly Niche Cancers 2001: Melanoma static version printer friendly pdf version Niche Cancers 2001: Pancreatic Cancer static version printer friendly Niche Cancers 2001: Renal Cell Carcinoma static version printer friendly pdf version Niche Cancers 2001: Sarcoma static version printer friendly pdf version Novel Strategies in Oncology Clinical Trials: The Use of Biological an... static version printer friendly pdf version Nuclear Oncology static version printer friendly pdf version ^ Top O Oncology Brand Commercialization: Resource Allocation static version printer friendly Oncology Market Forecast to 2013 static version printer friendly pdf version Oncology Market Opportunities, Strategies, and Forecasts, 2006 To 2012... static version printer friendly Oncology Partnering Agreements in Pharma, Biotech and Diagnostics static version printer friendly pdf version Oncology Pipelines: Is the Future Targeted Therapy? static version printer friendly pdf version Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 201... static version printer friendly pdf version Opportunities and Challenges in the Japanese Market for Cancer Therapi... static version printer friendly Optimizing Targeted Treatment in Cancer: Negotiating the Challenges to... static version printer friendly pdf version Oral Cancer Therapies: Barriers and Pathways to Reimbursement static version printer friendly Outlook for Cancer Vaccine Development static version printer friendly Oxford Handbook of Cancer Biology static version printer friendly pdf version Oxford Handbook of Cancer Epidemiology and Prevention, Third Edition static version printer friendly pdf version Oxford Handbook of Introduction to the Cellular and Molecular Biology ... static version printer friendly pdf version Oxford Handbook of Oncology, Second Edition static version printer friendly pdf version ^ Top P Pancreatic Cancer - Gold Standard Gemcitabine Waiting to be Challenged... static version printer friendly Pancreatic Cancer Drug Pipeline Report static version printer friendly pdf version Pancreatic Cancer Drug Pipeline Update 2009 static version printer friendly pdf version Pancreatic Cancer Therapy Area Pipeline Report static version printer friendly pdf version PET/CT and SPECT/CT To Plan and Monitor the Treatment of Cancer static version printer friendly pdf version Phenotypic and Genotypic Diagnosis of Malignancies: An Immunohistochem... static version printer friendly pdf version Pipeline Insight: Angiogenesis inibitors. Diversification and expansio... static version printer friendly pdf version Pipeline Insight: Cancer Overview - Increasing Diversity Offers Both H... static version printer friendly pdf version Pipeline Insight: Cancer Overview - Lung, Brain, Head and Neck, Thyroi... static version printer friendly pdf version Pipeline Insight: Cancer Overview - Numerous Diverse Drugs Approaching... static version printer friendly Pipeline Insight: Immunostimulators: Diversification and expansion of ... static version printer friendly pdf version Pipeline Insight: Molecular Targeted Cancer Therapies - More Pipeline ... static version printer friendly pdf version Pipeline Insight: Molecular Targeted Cancer Therapies: Can Anything El... static version printer friendly pdf version Pipeline Insight: Prostate Cancer - Domination By The Innovative Class... static version printer friendly Pipeline Insight: Therapeutic Cancer Vaccines - A Turbulent Path from ... static version printer friendly pdf version Pipeline Insight: Tumor-targeted agents: Diversification and expansion... static version printer friendly pdf version Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies - Mor... static version printer friendly pdf version Pipeline/Commercial Insight: Supportive Care In Oncology - Significant... static version printer friendly pdf version Prostate and Breast Cancer- New Treatments & Developmental Progress static version printer friendly pdf version Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2009 static version printer friendly pdf version Protein Kinase Therapeutics in Oncology - Where to Commercialize? static version printer friendly pdf version ^ Top R R&D Update: How Can Companies Improve on Existing Antiangiogenesis Age... static version printer friendly pdf version Radiation Oncology Equipment Assessment: A Survey of Twenty-Seven US-b... static version printer friendly pdf version Reaching Oncologists Online: Aligning Online Marketing Strategies with... static version printer friendly Recent Advances in Clinical Oncology static version printer friendly pdf version Regulator Perceptions in Cancer - Evolving Opinions about the Oncology... static version printer friendly pdf version Renal Cancer Drug Pipeline Update 2008 static version printer friendly pdf version Renal Cancer Drug Pipeline Update 2009 static version printer friendly pdf version ^ Top S Skin Cancer static version printer friendly pdf version Skin Cancer - Industry Background and Company News Updates static version printer friendly Stakeholder Insight: Adjunct Therapies in Breast Cancer static version printer friendly Stakeholder Insight: Breast Cancer Chemotherapy static version printer friendly Stakeholder Insight: Herceptin, The First of the Innovative Therapies static version printer friendly Stakeholder Insight: Hormonal Therapies in Breast Cancer static version printer friendly Stakeholder Insight: Lung Cancer - Third-Generation Cytotoxics Set to ... static version printer friendly pdf version Stakeholder Insight: Renal Cancer - Targeted therapies rapidly take ho... static version printer friendly pdf version Stakeholder Insight: Supportive Care in Cancer Treatment - Some First-... static version printer friendly pdf version Stakeholder Insight: The Screening and Diagnosis of Breast Cancer static version printer friendly Stakeholder Opinions: Cancer Cachexia - Higher Profile Needed to Unloc... static version printer friendly pdf version Stakeholder Opinions: Hepatocellular Carcinoma - Growing Market Seeks ... static version printer friendly Stakeholder Opinions: Hepatocellular Carcinoma - Opportune Indication ... static version printer friendly pdf version Stakeholder Opinions: Malignant Melanoma - High Hurdles, High Rewards,... static version printer friendly Stakeholder Opinions: Melanoma - Lucrative Commercial Opportunities Pe... static version printer friendly pdf version Stakeholder Opinions: Non-Hodgkins Lymphoma - Immunotherapy Stimulates... static version printer friendly Stakeholder Opinions: Ovarian Cancer - Beyond Carboplatin and Paclitax... static version printer friendly Stakeholder Opinions: Pancreatic Cancer - Gemzar Dominance will Contin... static version printer friendly pdf version Strategic Analysis of the European In Vitro Cancer Diagnostics Market static version printer friendly pdf version Strategic Assessment of Oncology Research and Opportunities in the Asi... static version printer friendly pdf version Strategic Outlook On Protein Kinase Inhibitors in Oncology static version printer friendly pdf version Strategic Perspective 2001: Female Cancers - Optimizing Market Opportu... static version printer friendly Strategic Perspectives 2001: Breast Cancer Cost Analysis static version printer friendly Strategic Perspectives 2001: Cancer Patient Power - Partnering With a ... static version printer friendly Strategic Perspectives 2001: Ovarian Cancer - Overview of Current and ... static version printer friendly pdf version Strategic Perspectives 2002: Cancer Adjunct Therapies static version printer friendly Strategic Perspectives 2002: Colorectal Cancer Cost Analysis static version printer friendly ^ Top T Target Atlas in Oncology Drug Development: Major Tumor Types static version printer friendly pdf version Target Atlas in Oncology Drug Development: Targeted Therapies static version printer friendly pdf version Target Product Profiles 2008: Physician Insights on Key Attributes - C... static version printer friendly pdf version Target Product Profiles 2008: Physician Insights on Key Attributes - C... static version printer friendly pdf version Target Product Profiles 2008: Physician Insights on Key Attributes - P... static version printer friendly pdf version Target-Based Approaches for Discovering Novel Oncology Drugs static version printer friendly pdf version Targeted Cancer Therapies: Innovative Drugs And Their Impact On The Fu... static version printer friendly The Asian Cancer Market Outlook to 2010 static version printer friendly The Biology and Treatment of Cancer: Understanding Cancer static version printer friendly pdf version The Biology of Cancer, 2nd Edition static version printer friendly pdf version The Cancer Clock static version printer friendly pdf version The Cancer Diagnostics Market: Emerging Opportunities And Business Exp... static version printer friendly pdf version The Cancer Market Outlook to 2008 static version printer friendly pdf version The Cancer Market Outlook to 2009 static version printer friendly The Cancer Market Outlook to 2010 static version printer friendly The Cancer Market Outlook to 2011 static version printer friendly pdf version The Cancer Market Outlook to 2012 static version printer friendly pdf version The Cancer Market Outlook to 2013: Competitive Landscape, Pipeline Ana... static version printer friendly pdf version The Cancer Outlook to 2007 static version printer friendly The Commercial Success of Cancer Therapeutic Antibodies - The Formatio... static version printer friendly The Complete Guide to Targeted Therapies in Oncology: A World Review static version printer friendly pdf version The Drug Target Atlas of Protein Kinase Inhibitors in Oncology static version printer friendly pdf version The Eastern European Cancer Market Outlook to 2010 static version printer friendly The Latin American Cancer Market Outlook to 2010 static version printer friendly The Prostate Cancer R&D Database static version printer friendly The Top 50 Oncology Contract Research Organisations In Europe static version printer friendly pdf version The War On Cancer - 2nd Edition static version printer friendly The World Cancer Market Yearbook 2005 static version printer friendly pdf version Therapeutic Peptides in Oncology - Favorable Conditions But Where to C... static version printer friendly pdf version Therapeutic Peptides in Oncology: Drug Pipeline Update 2009 static version printer friendly pdf version Therapeutics Targeting ERB Family static version printer friendly Thrombosis in Cancer - Expanding Focus for Anticoagulants static version printer friendly Thrombosis in Cancer: A New Challenge For Low Molecular Weight Heparin... static version printer friendly Top 20 Cancer Therapy Brands Forecast static version printer friendly pdf version Top 20 Manufacturers Of Point-Of-Care Diagnostics For Oncology static version printer friendly pdf version Top 20 Therapy Cancer Brands - Key Brands Set to Consolidate Advantage... static version printer friendly pdf version Top 7 Cancer Indications - Therapeutic & Competitive Insights static version printer friendly pdf version Treatment Algorithms 2001 Breast Cancer: Herceptin Falling into Stride... static version printer friendly Treatment Algorithms 2001: Lung Cancer static version printer friendly Treatment Algorithms 2001: Prostate Cancer static version printer friendly Treatment Algorithms: Cancer Pain - Physician Awareness and Novel Drug... static version printer friendly Trends in Cancer Treatment Drugs static version printer friendly pdf version Trends in the Commercialization of Biomarkers: Tests and Companies static version printer friendly pdf version Triple Analysis: Antibody Drug Target Atlas in Oncology and Special Fo... static version printer friendly pdf version Triple Analysis: Apoptosis Agents, Antibodies and Vaccines in Oncology... static version printer friendly pdf version Triple Analysis: Apoptosis Agents, Protein Kinase Inhibitors and Anti-... static version printer friendly pdf version Triple Analysis: Decoding Big Pharma's R&D Strategy in Oncology and Sp... static version printer friendly pdf version Triple Analysis: Protein Kinase Inhibitors, Antibodies and Vaccines in... static version printer friendly pdf version Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology ... static version printer friendly pdf version Triple Target Atlas in Oncology Drug Development static version printer friendly pdf version ^ Top U U.S. and European Brachytherapy Markets static version printer friendly pdf version U.S. Breast Disease Diagnosis and Therapy Markets static version printer friendly pdf version U.S. Cancer Molecular Diagnostics Markets static version printer friendly pdf version U.S. Cancer Support Therapies Markets static version printer friendly pdf version U.S. Cancer Vaccines Market static version printer friendly pdf version U.S. Digital and Computed Radiography Markets static version printer friendly pdf version U.S. Emerging Cancer Therapeutics Markets static version printer friendly pdf version U.S. Emerging Melanoma Therapeutics Markets static version printer friendly pdf version U.S. Market for Brachytherapy Products, 2002-2010 static version printer friendly pdf version U.S. Monoclonal Antibody Cancer Therapeutics Market static version printer friendly pdf version U.S. Multiple Myeloma Market static version printer friendly pdf version U.S. Radiopharmaceutical Agents Markets static version printer friendly pdf version U.S. Radiotherapy Market static version printer friendly pdf version U.S., European, and Japanese Cancer Therapeutics Markets static version printer friendly pdf version Update: The Cancer Outlook 2000 static version printer friendly US Cancer Pain Report static version printer friendly pdf version ^ Top V Viral Therapy of Cancer static version printer friendly pdf version ^ Top W What's Hot in Cancer Drug R&D? static version printer friendly pdf version Who's Developing What in New Cancer Drugs 2007? static version printer friendly pdf version World Cancer Assay Markets static version printer friendly pdf version Worldwide Cancer Drug Delivery Market, 2005-2015 static version printer friendly pdf version Worldwide Cancer Market: Trend Analysis static version printer friendly pdf version Worldwide Market for Oncology Diagnostic Testing, 2001-2010 static version printer friendly All rights reserved. © copyright 2008 Research and Markets Terms and conditions Privacy Policy